526139 — Transgene Biotek Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Transgene Biotek, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	C2023 March 31st	R2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	PRESS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.242	0.151	0.031	0.077	2.84
Net Total Accounts Receivable
Net Total Receivables	0.084	0.084	0.084	0	0
Total Inventory
Total Other Current Assets
Total Current Assets	6.53	6.98	10.4	11	12.6
Net Property, Plant And Equipment	20.3	18.5	17.6	16.7	32.9
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,569	1,471	1,424	324	342
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	142	92.1	105	110	126
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,346	1,297	1,310	393	418
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	222	174	114	-68.9	-75.7
Total Liabilities & Shareholders' Equity	1,569	1,471	1,424	324	342
Total Common Shares Outstanding